Add to a list

Inactive Instrument

Misonix, Inc. Stock

MSON

US6048711039

Medical Equipment, Supplies & Distribution

Analysts' recommendations: Misonix, Inc.

21-08-02	Misonix : BTIG Downgrades Misonix to Neutral From Buy	MT
21-07-30	Misonix : Craig-Hallum Downgrades Misonix to Hold From Buy; Price Target is $28	MT
21-07-30	Misonix : Canaccord Genuity Downgrades Misonix to Hold From Buy; Price Target is $28	MT

More recommendations

Managers and Directors: Misonix, Inc.

Manager	Title	Age	Since
John Joseph Salerno CMP	Compliance Officer	70	2015-02-28
Daniel Voic CTO	Chief Tech/Sci/R&D Officer	63	2001-12-31

More insiders

Misonix, Inc. (Misonix), is a medical devices company. The Company is engaged in designing, manufacturing and marketing of minimally invasive therapeutic ultrasonic medical devices. Its products include BoneScalpel Surgical System (BoneScalpel), SonicOne Wound Cleansing and Debridement System (SonicOne) and SonaStar Surgical Aspirator (SonaStar). BoneScalpel is used for surgical procedures involving the precise cutting and sculpting of bone while sparing soft tissue. SonaStar is used to emulsify and remove soft and hard tumors, primarily in the neuro and general surgery field. SonicOne offers tissue specific debridement and cleansing of wounds and burns for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The Company's products are nexus, BoneScalpel, SonaStar, SonicOne, TheraSkin and Therion.

Employees

281

Sector

Medical Equipment, Supplies & Distribution

More about the company

Stock Market
Stocks
MSON Stock

As early as today, start finding the best investment opportunities!

22-04-26	Misonix, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021	CI
21-11-01	Misonix, Inc.(NasdaqGM:MSON) dropped from S&P TMI Index	CI
21-11-01	Misonix, Inc.(NasdaqGM:MSON) dropped from S&P Global BMI Index	CI
21-10-29	Misonix, Inc.(NasdaqGM:MON) dropped from NASDAQ Composite Index	CI
21-10-28	Bioventus Inc. completed the acquisition of Misonix, Inc. from Stavros G. Vizirgianakis, SV Life Sciences Fund VI, L.P. and Sv Life Sciences Fund VI Strategic Partners, L.P., funds managed by SV Health Investors, LLC, 1315 Capital, LLC and others.	CI
21-09-02	Misonix : Q4 Net Loss Narrows, Revenue Surges	MT
21-09-02	Misonix : Earnings Flash (MSON) MISONIX Posts Q4 Revenue $19.7M	MT
21-09-02	Misonix, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021	CI
21-08-12	Misonix, Inc. Announces Nonrenewal of Allan Staley as President and Named Executive Officer	CI
21-08-02	Misonix : BTIG Downgrades Misonix to Neutral From Buy	MT
21-07-30	Misonix : Bioventus to Acquire Misonix in Cash-and-Stock Deal Valued at $518 Million	MT
21-07-30	NASDAQ 100 : Top Midday Gainers	MT
21-07-30	Misonix : Craig-Hallum Downgrades Misonix to Hold From Buy; Price Target is $28	MT

21-10-29	MISONIX INC : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
21-10-26	MISONIX INC : Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
21-10-18	MISONIX INC : Other Events (form 8-K)	AQ
21-09-02	MISONIX : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
21-09-02	MISONIX : REPORTS FOURTH QUARTER AND FISCAL YEAR 2021 FINANCIAL RESULTS (Form 8-K)	PU

Date	Insider	Type	Main position	Quantity	% Market Cap.
10/29/21	Patrick Beyer	Issuer sale	Director	20,000	0.1148%
10/29/21	Thomas Patton	Issuer sale	Director	104,500	0.5997%
10/29/21	SV Health Investors LLC	Issuer sale	Company	1,744,017	10.0087%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MISONIX, INC.	+4.74%	+2.95%	-	-	463M
ABBOTT LABORATORIES	+0.91%	+6.37%	-19.07%	+13.65%	178B
MEDTRONIC PLC	+1.32%	+8.89%	+0.22%	+33.17%	121B
STRYKER CORPORATION	+5.80%	+5.71%	-20.81%	+10.87%	108B
ESSILORLUXOTTICA	+0.41%	+3.99%	-44.97%	-10.22%	75.7B
CENCORA, INC.	+1.48%	+6.11%	+6.69%	+82.48%	64.15B
HOYA CORPORATION	-1.75%	-0.72%	+17.66%	+59.66%	53.49B
BECTON, DICKINSON AND COMPANY	+2.60%	+5.89%	+3.61%	-25.50%	51.45B
IDEXX LABORATORIES, INC.	+3.40%	+6.17%	-14.76%	+26.83%	41.68B
DEXCOM, INC.	+5.13%	+3.53%	+33.60%	+10.69%	31.5B
Average	+2.31%	+3.49%	-4.20%	+22.40%	80.52B
Weighted average by Cap.	+1.91%	+4.21%	-9.69%	+21.33%

Misonix, Inc. Stock

Stocks

MSON

US6048711039

Medical Equipment, Supplies & Distribution

Latest news: Misonix, Inc.

Analysts' recommendations: Misonix, Inc.

Press Releases: Misonix, Inc.

Quotes and Performance

Managers and Directors: Misonix, Inc.

Latest insider transactions

Medical Equipment

Company Profile